Protocatechuic Acid Suppresses Lipid Uptake and Synthesis through the PPARγ Pathway in High-Fat Diet-Induced NAFLD Mice

被引:3
作者
Li, Jia [1 ]
Li, Chaoyue [1 ]
Wu, Xue [1 ]
Dong, Yonghui [1 ]
Li, Yunlong [2 ]
Jiao, Xiaowen [1 ]
Li, Jiating [1 ]
Han, Lin [1 ]
Wang, Min [1 ]
机构
[1] Northwest A&F Univ, Coll Food Sci & Engn, Yangling 712100, Peoples R China
[2] Shanxi Agr Univ, Inst Funct Food Shanxi, Taiyuan 030006, Peoples R China
关键词
protocatechuic acid; nonalcoholicfatty liver disease; proteomics; PPAR gamma; INDUCED HEPATIC STEATOSIS; LIVER; CD36; CONTRIBUTES; EXPRESSION; OBESITY;
D O I
10.1021/acs.jafc.4c01354
中图分类号
S [农业科学];
学科分类号
09 ;
摘要
Nonalcoholic fatty liver disease (NAFLD) has become one of the most concerning health problems in the world. Dietary intervention is an effective way to prevent and improve NAFLD. As one of the main metabolites of anthocyanins, protocatechuic acid (PCA) exhibited strong activity to improve NAFLD, but the specific mechanism remains unclear. Currently, proteomics has been used to identify that PCA treatment could significantly influence the expression of 224 proteins, including 89 downregulated proteins and 135 upregulated proteins. KEGG analysis showed that PCA obviously inhibited the peroxisome proliferator-activated receptor (PPAR) signaling pathway. Immunofluorescence and Western blot analyses further confirmed that PCA repressed the protein expression of PPAR gamma and subsequently inhibited the expression of free fatty acid (FFA) uptake proteins (CD36 and FABP2) and FFA synthesis proteins (ACC and FASN), respectively. These effects of PCA contributed to the inhibitory activity of excessive lipid accumulation in the liver. Our results highlighted that PCA could effectively alleviate high-fat diet-induced (HFD) NAFLD by inhibiting lipid absorption and synthesis through the PPAR gamma signaling pathway.
引用
收藏
页码:4012 / 4026
页数:15
相关论文
共 35 条
[1]   ACC inhibitor alone or co-administered with a DGAT2 inhibitor in patients with non-alcoholic fatty liver disease: two parallel, placebo-controlled, randomized phase 2a trials [J].
Calle, Roberto A. ;
Amin, Neeta B. ;
Carvajal-Gonzalez, Santos ;
Ross, Trenton T. ;
Bergman, Arthur ;
Aggarwal, Sudeepta ;
Crowley, Collin ;
Rinaldi, Anthony ;
Mancuso, Jessica ;
Aggarwal, Naresh ;
Somayaji, Veena ;
Inglot, Malgorzata ;
Tuthill, Theresa A. ;
Kou, Kou ;
Boucher, Magalie ;
Tesz, Greg ;
Dullea, Robert ;
Bence, Kendra K. ;
Kim, Albert M. ;
Pfefferkorn, Jeffrey A. ;
Esler, William P. .
NATURE MEDICINE, 2021, 27 (10) :1836-+
[2]   Research progress on intervention effect and mechanism of protocatechuic acid on nonalcoholic fatty liver disease [J].
Gao, Yunxiao ;
Tian, Rongrong ;
Liu, Haiyue ;
Xue, Huimin ;
Zhang, Ruizhe ;
Han, Suping ;
Ji, Lin ;
Huang, Weidong ;
Zhan, Jicheng ;
You, Yilin .
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, 2022, 62 (32) :9053-9075
[3]   Effects of rosiglitazone on the liver histology and mitochondrial function in ob/ob mice [J].
Garcia-Ruiz, Inmaculada ;
Rodriguez-Juan, Cristina ;
Diaz-Sanjuan, Teresa ;
Angel Martinez, Miguel ;
Munoz-Yague, Teresa ;
Solis-Herruzo, Jose A. .
HEPATOLOGY, 2007, 46 (02) :414-423
[4]   Liver peroxisome proliferator-activated receptor γ contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass [J].
Gavrilova, O ;
Haluzik, M ;
Matsusue, K ;
Cutson, JJ ;
Johnson, L ;
Dietz, KR ;
Nicol, CJ ;
Vinson, C ;
Gonzalez, FJ ;
Reitman, ML .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (36) :34268-34276
[5]   Acetyl-CoA Carboxylase Inhibition Reverses NAFLD and Hepatic Insulin Resistance but Promotes Hypertriglyceridemia in Rodents [J].
Goedeke, Leigh ;
Bates, Jamie ;
Vatner, Daniel F. ;
Perry, Rachel J. ;
Wang, Ting ;
Ramirez, Ricardo ;
Li, Li ;
Ellis, Matthew W. ;
Zhang, Dongyan ;
Wong, Kari E. ;
Beysen, Carine ;
Cline, Gary W. ;
Ray, Adrian S. ;
Shulman, Gerald I. .
HEPATOLOGY, 2018, 68 (06) :2197-2211
[6]   Transcriptional regulation of Glis2 in hepatic fibrosis [J].
Gong, Huan-Yu ;
Zhou, Peng-Cheng ;
Zhang, Hao-Ye ;
Chen, Li-Min ;
Zhou, Yang-Mei ;
Liu, Zhen-Guo .
EXPERIMENTAL AND MOLECULAR MEDICINE, 2023, 55 (07) :1462-1478
[7]   Protocatechuic Acid-Ameliorated Endothelial Oxidative Stress through Regulating Acetylation Level via CD36/AMPK Pathway [J].
Han, Lin ;
Yang, Qing ;
Li, Jia ;
Cheng, Feier ;
Zhang, Yao ;
Li, Yunlong ;
Wang, Min .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2019, 67 (25) :7060-7072
[8]   Protective Mechanism of Common Buckwheat (Fagopyrum esculentum Moench.) against Nonalcoholic Fatty Liver Disease Associated with Dyslipidemia in Mice Fed a High-Fat and High-Cholesterol Diet [J].
Huang, Zi-Rui ;
Deng, Jia-Cong ;
Li, Qiu-Yi ;
Cao, Ying-Jia ;
Lin, Yi-Chen ;
Bai, Wei-Dong ;
Liu, Bin ;
Rao, Ping-Fan ;
Ni, Li ;
Lv, Xu-Cong .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2020, 68 (24) :6530-6543
[9]   Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity [J].
Koonen, Debby P. Y. ;
Jacobs, Rene L. ;
Febbraio, Maria ;
Young, Martin E. ;
Soltys, Carrie-Lynn M. ;
Ong, Huy ;
Vance, Dennis E. ;
Dyck, Jason R. B. .
DIABETES, 2007, 56 (12) :2863-2871
[10]   The many faces of PPARγ [J].
Lehrke, M ;
Lazar, MA .
CELL, 2005, 123 (06) :993-999